Xinming Zhao Selected Research

Extranodal NK-T-Cell Lymphoma

12/2021

The promising outcome with simultaneous integrated boost intensity modulated radiotherapy in confined nasal extranodal NK/T-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinming Zhao Research Topics

Disease

49	Neoplasms (Cancer) 05/2024 - 09/2011
14	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 12/2014
10	Rectal Neoplasms (Rectal Cancer) 01/2023 - 01/2018
8	Breast Neoplasms (Breast Cancer) 10/2023 - 01/2016
7	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024 - 09/2011
7	Neoplasm Metastasis (Metastasis) 04/2024 - 10/2019
6	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 05/2002
6	Adenocarcinoma of Lung 11/2022 - 09/2016
4	Stomach Neoplasms (Stomach Cancer) 04/2024 - 10/2021
4	Fibrosis (Cirrhosis) 04/2024 - 01/2022
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2020
4	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2023 - 01/2022
3	Adenocarcinoma 07/2023 - 09/2011
3	Nasopharyngeal Carcinoma 12/2022 - 01/2022
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2022 - 04/2022
2	Lymphatic Metastasis 04/2024 - 11/2022
2	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 06/2015
2	Hypertension (High Blood Pressure) 02/2022 - 03/2015
2	Thyroid Neoplasms (Thyroid Cancer) 02/2022 - 11/2017
2	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2019
2	Necrosis 01/2020 - 03/2015
2	Carcinoma (Carcinomatosis) 05/2017 - 06/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024
1	Sarcopenia 12/2023
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2023
1	Triple Negative Breast Neoplasms 10/2023
1	Squamous Cell Carcinoma of Head and Neck 07/2023
1	Hepatitis 05/2023
1	Pituitary Neoplasms (Pituitary Adenoma) 08/2022
1	Insulinoma 08/2022
1	Hypoglycemia (Reactive Hypoglycemia) 08/2022
1	Diarrhea 02/2022
1	Proteinuria 02/2022
1	Hand-Foot Syndrome 02/2022
1	Disease Progression 01/2022
1	Extranodal NK-T-Cell Lymphoma 12/2021
1	Lymphoma (Lymphomas) 12/2021
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 07/2021
1	Liver Neoplasms (Liver Cancer) 06/2021
1	Liver Diseases (Liver Disease) 06/2021
1	Dehydration (Water Stress) 06/2021

Drug/Important Bio-Agent (IBA)

10	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2024 - 01/2020
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2011
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2019
5	AlbuminsIBA 04/2024 - 01/2022
4	ErbB Receptors (EGF Receptor)IBA 01/2020 - 06/2014
3	Capsules (Microcapsules)IBA 01/2024 - 01/2023
3	AntigensIBA 07/2023 - 01/2019
3	Tyrosine Kinase InhibitorsIBA 10/2020 - 09/2016
3	Pemetrexed (MTA)FDA Link 01/2020 - 01/2018
2	68Ga-FAPIIBA 04/2024 - 01/2022
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2024 - 01/2022
2	BilirubinIBA 04/2024 - 11/2023
2	CarbohydratesIBA 07/2023 - 01/2023
2	Immune Checkpoint InhibitorsIBA 01/2023 - 10/2020
2	Carcinoembryonic AntigenIBA 01/2023 - 07/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 10/2019
2	Therapeutic UsesIBA 01/2023 - 01/2022
2	IodineIBA 02/2022 - 03/2015
2	human ERBB2 proteinIBA 01/2022 - 06/2015
2	regorafenibIBA 09/2021 - 08/2021
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2021 - 01/2019
2	IntegrinsIBA 06/2021 - 11/2018
2	Protons (Proton)IBA 08/2020 - 09/2011
2	Choline (Choline Chloride)IBA 08/2016 - 09/2011
1	Circular RNAIBA 01/2024
1	CytokinesIBA 01/2024
1	EnzymesIBA 01/2024
1	ImmunosorbentsIBA 01/2024
1	gadolinium ethoxybenzyl DTPA FDA Link 11/2023
1	Glucose (Dextrose)FDA LinkGeneric 10/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2023
1	gallium Ga 68 dotatateIBA 08/2022
1	apatinibIBA 02/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2022
1	Fumigant 93 (D-D)IBA 10/2021
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 06/2021
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 06/2021
1	Peptides (Polypeptides)IBA 06/2021
1	ferric ferrocyanide (Prussian blue)FDA Link 06/2021

Therapy/Procedure

14	Neoadjuvant Therapy 04/2024 - 01/2016
13	Therapeutics 01/2024 - 06/2015
8	Radiotherapy 05/2024 - 05/2017
8	Chemoradiotherapy 07/2023 - 01/2022
4	Immunotherapy 01/2024 - 09/2023
3	Hepatectomy 05/2023 - 07/2019
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 12/2022 - 12/2021
3	Drug Therapy (Chemotherapy) 10/2021 - 01/2020
2	Mastectomy (Mammectomy) 10/2023 - 01/2022
2	Surgical Instruments (Clip) 12/2022 - 04/2021
2	Radiofrequency Ablation 04/2019 - 12/2014
1	Segmental Mastectomy (Lumpectomy) 10/2023
1	Intravenous Injections 01/2023
1	Adjuvant Chemotherapy 01/2023
1	Precision Medicine 01/2023
1	Aftercare (After-Treatment) 01/2022
1	Drug Tapering 12/2021
1	Lasers (Laser) 06/2021